Anavex Life Sciences Corp (AVXL)

[boi568]

Also, comparing today's PR to the December 1st PR, the revised stat for cognitive slowing moved from 45 percent to 43 percent improvement,* assuming the placebo decline figure remains the same. This is not a meaningful difference, but it does indicate the initial figure was not fully vetted.

* The company doesn't present it in those terms, instead referencing today a 1.783 point improvement versus an initially reported 1.85 point improvement (1.783/4.11 versus 1.85/4.11), or .43 versus .45).